norfluoxetine has been researched along with Puerperal Disorders in 3 studies
norfluoxetine: metabolite of fluoxetine; RN given refers to parent cpd without isomeric designation
Puerperal Disorders: Disorders or diseases associated with PUERPERIUM, the six-to-eight-week period immediately after PARTURITION in humans.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Epperson, CN | 1 |
| Jatlow, PI | 1 |
| Czarkowski, K | 1 |
| Anderson, GM | 1 |
| Burch, KJ | 1 |
| Wells, BG | 1 |
| Isenberg, KE | 1 |
3 other studies available for norfluoxetine and Puerperal Disorders
| Article | Year |
|---|---|
Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs.
Topics: Adult; Blood Platelets; Depressive Disorder; Female; Fluoxetine; Half-Life; Humans; Infant; Infant, | 2003 |
Fluoxetine/norfluoxetine concentrations in human milk.
Topics: Adult; Breast Feeding; Depression; Female; Fluoxetine; Humans; Infant; Infant, Newborn; Milk, Human; | 1992 |
Excretion of fluoxetine in human breast milk.
Topics: Adult; Breast Feeding; Depressive Disorder; Female; Fluoxetine; Humans; Infant, Newborn; Milk, Human | 1990 |